Palisade Bio Analyst Ratings
Palisade Bio Analyst Ratings
While ratings are subjective and will change, the latest Palisade Bio (PALI) rating was a downgraded with a price target of $0.00 to $0.00. The current price Palisade Bio (PALI) is trading at is $0.16, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/19/2022 | — | Maxim Group | Downgrades | Buy → Hold | |
| 02/02/2022 | 2946.92% | Ladenburg Thalmann | → $5 | Initiates Coverage On | → Buy |
| 08/31/2021 | 4165.69% | Maxim Group | → $7 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 2022 年 8 月 19 日 | — | Maxim 集团 | 降级 | 买入 → 持有 | |
| 02/02/2022 | 2946.92% | 拉登堡塔尔曼 | → 5 美元 | 启动覆盖范围开启 | → 购买 |
| 08/31/2021 | 4165.69% | Maxim 集团 | → 7 美元 | 启动覆盖范围开启 | → 购买 |
Palisade Bio Questions & Answers
Palisade 生物问题与解答
The latest price target for Palisade Bio (NASDAQ: PALI) was reported by Maxim Group on August 19, 2022. The analyst firm set a price target for $0.00 expecting PALI to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
Maxim集团于2022年8月19日公布了Palisade Bio（纳斯达克股票代码：PALI）的最新目标股价。该分析公司将目标股价定为0.00美元，预计PALI将在12个月内降至12个月内（可能下跌-100.00％）。去年有3家分析公司公布了评级。
The latest analyst rating for Palisade Bio (NASDAQ: PALI) was provided by Maxim Group, and Palisade Bio downgraded their hold rating.
Palisade Bio（纳斯达克股票代码：PALI）的最新分析师评级由Maxim集团提供，Palisade Bio下调了持有评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Palisade Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Palisade Bio was filed on August 19, 2022 so you should expect the next rating to be made available sometime around August 19, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Palisade Bio的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Palisade Bio的最新评级是在2022年8月19日发布的，因此您应该预计下一个评级将在2023年8月19日左右公布。
While ratings are subjective and will change, the latest Palisade Bio (PALI) rating was a downgraded with a price target of $0.00 to $0.00. The current price Palisade Bio (PALI) is trading at is $0.16, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Palisade Bio（PALI）评级已下调，目标股价为0.00美元至0.00美元。Palisade Bio（PALI）目前的交易价格为0.16美元，超出了分析师的预期区间。
